Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Enterprise Value: 2009-2024

Historic Enterprise Value for Avadel Pharmaceuticals (AVDL) over the last 14 years, with Dec 2024 value amounting to $1.0 billion.

  • Avadel Pharmaceuticals' Enterprise Value fell 50.89% to $193.1 million in Q3 2022 from the same period last year, while for Sep 2022 it was -$191.7 million, marking a year-over-year increase of 18.78%. This contributed to the annual value of $1.0 billion for FY2024, which is N/A change from last year.
  • Latest data reveals that Avadel Pharmaceuticals reported Enterprise Value of $1.0 billion as of FY2024, which was up 220.06% from $316.4 million recorded in FY2021.
  • In the past 5 years, Avadel Pharmaceuticals' Enterprise Value ranged from a high of $1.0 billion in FY2024 and a low of $167.9 million during FY2020.
  • Over the past 1 years, Avadel Pharmaceuticals' median Enterprise Value value was $1.0 billion (recorded in 2024), while the average stood at $1.0 billion.
  • Its Enterprise Value has fluctuated over the past 5 years, first dropped by 23.21% in 2020, then surged by 88.51% in 2021.
  • Avadel Pharmaceuticals' Enterprise Value (Yearly) stood at $167.9 million in 2020, then skyrocketed by 88.51% to $316.4 million in 2021, then reached $1.0 billion in 2024.